Bone Biologics Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
Bone Biologics is a publicly held biotechnology company in Los Angeles focused on regenerative medicine for orthopedics. It operates as a spin-off linked to the Musculoskeletal Transplant Foundation and relies on technology discovered and licensed from UCLA, with origins dating to 2004 when UC professors collaborated with Osaka University and a USC surgeon. The firm maintains a small team and oversees a proprietary platform, UCB-1, licensed from UCLA, which is positioned to support bone repair and regeneration across multiple applications. Its lead product program centers on Nell-1 for bone regeneration in lumbar spinal fusion, currently under development toward near-term clinical testing. A recent development includes launching an NB1 spinal fusion pilot in Australia in 2024, reflecting continued progress in its spine-focused regenerative medicine approach.